3Tsutamoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ,ventricular dysfunction [J]. Eur Heart J, 1999, 20 (24) : 1799-1807.
4Trachsel DS, Grenacher B, Weishaupt MA, et al. Plasma atrial natri- uretic peptide concentrations in horses with heart disease: a pilot study [J] . Vet J, 2012, 192 (2) : 166 -170.
5Chen Y, Wu Z, Yang C, et al. Investigation of atrial vulnerability by a- nalysis of the sinus node EG from atrial fibrillation models using a phase synchronization method[J]. IEEE Trans Biomed Eng, 2012, 59 (9) : 2668-2676.
6Olofsson SO, BorOn J. Apolipoprotein B: a clinically important apoli- poprotein which assembles atherogenic lipoproteins and promotes the de- velopment of atherosclerosis[J]. J Intern Med, 2005, 258 ( 5 ) : 395-410.
7Kato H, Mizuno T, Mizuno M, et al. Atrial'natriuretic peptide amelio-rates peritoneal fibrosis in rat peritonitis model [J]. Nephrol Dial Transplant, 2012, 27 (2) : 526-536.
8戴洁.心血管疾病护理的探讨[J].医药前沿,2014,(5):272-273.
9Zung WWK.A rating instrument for anxiety disorders[J].Psychosomatics.1971;12(6):371-379.
10Zung WWK.A self-rating depression scale[J].Arch Gen Psychiatry.1965,12:63-70.
